New research in the Lancet suggests a potential vaccine clears plaques in people with dementia but does not slow progression of the disease
Published 18 July 2008
Amyloid plaques form in the brains of people with Alzheimer’s disease.
It is encouraging that this drug successfully removes these plaques, but disappointing that these initial results suggest it did not slow the progression of the disease.
More detailed evaluations of the effects of this drug are now taking place and larger clinical trials are underway. We look forward to the outcomes to establish the effectiveness of this vaccine.
Susanne Sorensen
Head of Research
Alzheimer's Society
Find out more about dementia - take a look at our factsheets